Australia markets closed

Nephros, Inc. (NEPH)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.4600-0.0100 (-0.68%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-1,294
-1,575
-7,382
-4,107
-4,766
-
Depreciation & amortisation
176
214
351
252
208
-
Stock-based compensation
565
1,052
982
1,259
779
-
Change in working capital
-665
830
432
883
-3,493
-
Accounts receivable
-313
-221
357
-278
-333
-
Inventory
-1,046
387
765
296
-2,762
-
Accounts payable
859
133
-593
908
-538
-
Other working capital
-978
752
-3,371
-1,453
-7,142
-
Other non-cash items
-
-
353
321
97
201
Net cash provided by operating activities
-848
827
-3,234
-1,417
-6,903
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-75
-137
-36
-239
-
Acquisitions, net
-
-
-
-
0
-137
Other investing activities
-
-
-
-49
-
-
Net cash used for investing activities
-125
-75
-137
-85
-239
-
Cash flows from financing activities
Debt repayment
-7
-79
-286
-264
-800
-
Common stock issued
-
-
-
0
11,452
1,992
Other financing activities
-
-
157
-
-85
-94
Net cash used provided by (used for) financing activities
-7
-79
34
237
11,216
-
Net change in cash
-980
673
-3,339
-1,276
4,083
-
Cash at beginning of period
4,060
3,634
6,973
8,249
4,166
-
Cash at end of period
3,080
4,307
3,634
6,973
8,249
-
Free cash flow
Operating cash flow
-848
827
-3,234
-1,417
-6,903
-
Capital expenditure
-
-75
-137
-36
-239
-
Free cash flow
-978
752
-3,371
-1,453
-7,142
-